INVITRO EMERGENCE OF QUINOLONE-RESISTANT MUTANTS OF ESCHERICHIA-COLI, ENTEROBACTER-CLOACAE, AND SERRATIA-MARCESCENS

被引：36

作者：

WATANABE, M ^{[1
]}

KOTERA, Y ^{[1
]}

YOSUE, K ^{[1
]}

INOUE, M ^{[1
]}

MITSUHASHI, S ^{[1
]}

机构：

[1] GUNMA UNIV,SCH MED,DRUG RESISTANCE BACTERIA LAB,MAEBASHI,GUNMA 371,JAPAN

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1990年 / 34卷 / 01期

关键词：

D O I：

10.1128/AAC.34.1.173

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Norfloxacin- and ciprofloxacin-resistant mutants of several Enterobacter cloacae and Serratia marcescens isolates occurred at frequencies of ≥ 10-7/CFU, which were higher than those of Escherichia coli isolates, in accordance with the increasing emergence of less-susceptible or resistant strains in clinical isolates of E. cloacae and S. marcescens.

引用

页码：173 / 175

页数：3

共 14 条

[1] CLINICAL ISOLATE OF CITROBACTER-FREUNDII HIGHLY RESISTANT TO NEW QUINOLONES [J].

AOYAMA, H ;

FUJIMAKI, K ;

SATO, K ;

FUJII, T ;

INOUE, M ;

HIRAI, K ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (06) :922-924

[2] ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].

COHEN, SP ;

HOOPER, DC ;

WOLFSON, JS ;

SOUZA, KS ;

MCMURRY, LM ;

LEVY, SB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191

[3] COMPARATIVE INVITRO ACTIVITY OF A NEW FLUORINATED 4-QUINOLONE, T-3262 (A-60969) [J].

ESPINOZA, AM ;

CHIN, NX ;

NOVELLI, A ;

NEU, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :663-670

[4] THE FREQUENCY OF INVITRO RESISTANCE DEVELOPMENT TO FLUOROQUINOLONES AND THE USE OF A MURINE PYELONEPHRITIS MODEL TO DEMONSTRATE SELECTION OF RESISTANCE INVIVO [J].

FERNANDES, PB ;

HANSON, CW ;

STAMM, JM ;

VOJTKO, C ;

SHIPKOWITZ, NL ;

STMARTIN, E .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 19 (04) :449-465

[5] CROSS-RESISTANCE TO NALIDIXIC-ACID, TRIMETHOPRIM, AND CHLORAMPHENICOL ASSOCIATED WITH ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF KLEBSIELLA, ENTEROBACTER, AND SERRATIA [J].

GUTMANN, L ;

WILLIAMSON, R ;

MOREAU, N ;

KITZIS, MD ;

COLLATZ, E ;

ACAR, JF ;

GOLDSTEIN, FW .

JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :501-507

[6] ESCHERICHIA COLI K-12 MUTANTS RESISTANT TO NALIDIXIC ACID - GENETIC MAPPING AND DOMINANCE STUDIES [J].

HANE, MW ;

WOOD, TH .

JOURNAL OF BACTERIOLOGY, 1969, 99 (01) :238-&

[7] ISOLATION AND CHARACTERIZATION OF NORFLOXACIN-RESISTANT MUTANTS OF ESCHERICHIA-COLI K-12 [J].

HIRAI, K ;

AOYAMA, H ;

SUZUE, S ;

IRIKURA, T ;

IYOBE, S ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :248-253

[8] GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].

HOOPER, DC ;

WOLFSON, JS ;

SOUZA, KS ;

TUNG, C ;

MCHUGH, GL ;

SWARTZ, MN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644

[9] ROLE OF PORIN PROTEINS OMPF AND OMPC IN THE PERMEATION OF BETA-LACTAMS [J].

JAFFE, A ;

CHABBERT, YA ;

SEMONIN, O .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) :942-948

[10] INVITRO AND INVIVO ANTI-BACTERIAL ACTIVITY OF AT-2266 [J].

KOUNO, K ;

INOUE, M ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (01) :78-84

← 1 2 →